DMAAR vs ENPH · $1.8M cap vs P/E 56, rev $1.47B
Drugs Made In America Acquisition Corp. Rights (DMAAR) versus Enphase Energy Inc (ENPH) — a side-by-side from cached financials, not a winner call.
Drugs Made In America Acquisition Corp. Rights (DMAAR) common stock listed on US.
Enphase Energy Inc (ENPH) is a solar company listed on US.
DMAAR does not have a complete income-statement cache yet.
Latest reported ENPH revenue for 2025-12-31 was $1.47B. Net income was $172.1M. Revenue was up 10.7% from 2024-12-31 to 2025-12-31. ENPH currently screens at market cap $7.39B and trailing P/E 55.5.
DMAAR currently screens at market cap $1.8M. ENPH currently screens at market cap $7.39B and trailing P/E 55.5.
Not investment advice. Open the DMAAR and ENPH stock pages for the full models.
Not investment advice.